Establishment Labs wins FDA approval for additional Motiva breast implant sizes in US
Bitget2026/10/05 12:15FDA cleared an expanded U.S. size range for Motiva SmoothSilk Round and Ergonomix breast implants from Establishment Labs. Regulatory decision adds 28 new implant sizes, extending the portfolio down to 105 cc. Company expects the newly cleared sizes to be commercially available in the U.S. before year-end. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Establishment Labs Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610050800BIZWIRE_USPR_____20261005_BW325654) on October 05, 2026, and is solely responsible for the information contained therein.
- FDA cleared an expanded U.S. size range for Motiva SmoothSilk Round and Ergonomix breast implants from Establishment Labs.
- Regulatory decision adds 28 new implant sizes, extending the portfolio down to 105 cc.
- Company expects the newly cleared sizes to be commercially available in the U.S. before year-end.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Only 1.45 Billion Shiba Inu (SHIB) Burned in 24 Hours Hints at Reversal
Viral Altcoin Defies Market Slumber With 53% Surge, BTC Calms at $83K: Weekend Watch
Global Bank Stocks Sink as Bond Losses Top $326 Billion: Is Another SVB Coming?
Crypto prices
More
